Por: The Boston Globe Business October 12, 2022
Competition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that tinkering with RNA — the shorter-lived cousin to DNA — might be a safer and more effective strategy for some conditions.Ascidian Therapeutics, the latest entrant to... + full article
Business Insider USA Business October 14, 2022
In the past few years, investors have bet billions on healthcare startups looking to disrupt the industry. In 2022, that activity has started to cool off and companies postpone their public debuts. Even so, healthcare startups raised $15.8 billion in the first half of the year,... + más
Snakes In The Garden Of ESG: 5 Strategies To Make ESG VC More Successful | Forbes
South Florida doctor to bridge healthcare gap in Pahokee | WPTV
The Boston Globe USA Nation October 12, 2022
Some big changes are coming to the nation’s oldest park, according to the new Boston Common Master Plan unveiled Wednesday.Here’s a look at some of the ways the roughly 50-acre space could be transformed, a process that could be rolled out over the next decade.Related: A map... + más
Revamped observatory set to open atop Prudential tower in 2023 | The Boston Globe
A new master plan could help transform Boston Common into a ‘better version’ of itself | The Boston Globe
The Daily Beast USA World October 11, 2022
As the wave of from the highly-contagious finally subsided back in late July, new subvariants were already competing for dominance—and the opportunity to drive the next wave of infections.A little over two months later, epidemiologists are close to naming a winner. In the... + más
Dreaded Side Effect Rears Its Ugly Head in Latest COVID Variant | The Daily Beast
Pumpkin shaped baked brie is perfect for fall | ABC News
The Boston Globe USA Tech October 04, 2022
Ginkgo Bioworks, the Boston-based synthetic biology company, said Tuesday that it has acquired two biotech companies, Altar and Circularis.Terms of the deals were not disclosed. Atlas has fewer than 20 employees and Circularis has fewer than 10. The acquisitions come as Ginkgo... + más
Dr. Renee Wegrzyn Named Inaugural Director Of ARPA-H | RTTNews
LabCentral opens its biggest site yet in the heart of Kendall Square | The Boston Globe
Forbes USA Business September 29, 2022
Conviction, high risk tolerance, and resilience is something most startup founders share. Even ... [+] though these qualities are extremely valuable, in certain circumstances they could create problems.getty When it comes to personality, there’s no good or bad - there are only... + más
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
This is the smart way for the U.S. to respond to Putin's hints over nuclear weapons | MarketWatch
The Boston Globe USA Tech September 20, 2022
How are startup people feeling about the startup ecosystem in Boston now — from remote work to funding to making the city more fun?I conducted a survey in August, collecting more than 200 responses from an array of founders, startup employees, investors, and providers of... + más
Jody Rose and Jeff Bussgang are tackling tech’s diversity problem | The Boston Globe
Introducing the Globe’s Tech Power Players 50 — and how it came together | The Boston Globe
The Advocate USA Health September 17, 2022
What is meant by talking therapy?Talking therapies include counseling, psychotherapy and cognitive behavioral therapy and can help individuals understand the often-missing link between actions, feelings and thoughts. Talking therapies can be effective for individuals in the... + más
Variety of factors play a role in the development of Alzheimer's | The Advocate
Alzheimer's Q&A: Be present for affected friends, family | The Advocate
About iurex | Privacy Policy | Disclaimer |